Death rates have fallen generally since the Northern Hemisphere Spring started, some people attributing this to SOC increasing which I believe may have played a small part of the reduction.

My thoughts are as follows:

If one gets a cold or flu in winter it generally affects their respiratory system more than if they got infected during summer.

On this basis I believe, with colder weather approaching the death rate will be increasing once again.

Therefore, due to the possibility of placebo deaths increasing, I see trial continuation may in fact boost our chance of approval even further.